38 related articles for article (PubMed ID: 28803047)
1. Synthesis and biological evaluation of salicylate-based compounds as a novel class of methionine aminopeptidase inhibitors.
Wang WL; Chai SC; Ye QZ
Bioorg Med Chem Lett; 2011 Dec; 21(23):7151-4. PubMed ID: 22001086
[TBL] [Abstract][Full Text] [Related]
2. Bestatin attenuates breast cancer stemness by targeting puromycin-sensitive aminopeptidase.
Ma Y; Yang X; Pan P; Yang J; Wu X; Wang D; Gao H
Discov Oncol; 2024 May; 15(1):197. PubMed ID: 38814491
[TBL] [Abstract][Full Text] [Related]
3. Modulation of endogenous opioid signaling by inhibitors of puromycin sensitive aminopeptidase.
Singh R; Jiang R; Williams J; Dobariya P; Hanak F; Xie J; Rothwell PE; Vince R; More SS
bioRxiv; 2024 Apr; ():. PubMed ID: 38617237
[TBL] [Abstract][Full Text] [Related]
4. Drug repurposing based on differentially expressed genes suggests drug combinations with possible synergistic effects in treatment of lung adenocarcinoma.
Yesharim L; Teimourian S
Cancer Biol Ther; 2023 Dec; 24(1):2253586. PubMed ID: 37710391
[TBL] [Abstract][Full Text] [Related]
5. Structure of puromycin-sensitive aminopeptidase and polyglutamine binding.
Madabushi S; Chow KM; Song ES; Goswami A; Hersh LB; Rodgers DW
PLoS One; 2023; 18(7):e0287086. PubMed ID: 37440518
[TBL] [Abstract][Full Text] [Related]
6. The Recurrent-Specific Regulation Network of Prognostic Stemness-Related Signatures in Low-Grade Glioma.
Li J; Zhou M; Huang D; Lin R; Cui X; Chen S; Yao Y; Xian S; Wang S; Fu Q; Zhu J; Yue X; Huang R; Qi E; Huang Z
Dis Markers; 2023; 2023():2243928. PubMed ID: 36703644
[TBL] [Abstract][Full Text] [Related]
7. Rapid imaging of lung cancer using a red fluorescent probe to detect dipeptidyl peptidase 4 and puromycin-sensitive aminopeptidase activities.
Kawashima S; Yoshida D; Yoshioka T; Ogasawara A; Fujita K; Yanagiya M; Nagano M; Konoeda C; Hino H; Kitano K; Sato M; Hino R; Kojima R; Komatsu T; Kamiya M; Urano Y; Nakajima J
Sci Rep; 2022 Jun; 12(1):9100. PubMed ID: 35650221
[TBL] [Abstract][Full Text] [Related]
8. Pan-Cancer Analyses Confirmed the Ferroptosis-Related Gene
Lin Y; Dong Y; Liu W; Fan X; Sun Y
Int J Gen Med; 2022; 15():2501-2513. PubMed ID: 35282646
[TBL] [Abstract][Full Text] [Related]
9. Integrative Analysis of a Novel Eleven-Small Nucleolar RNA Prognostic Signature in Patients With Lower Grade Glioma.
Deng T; Gong Y; Liao X; Wang X; Zhou X; Zhu G; Mo L
Front Oncol; 2021; 11():650828. PubMed ID: 34164339
[TBL] [Abstract][Full Text] [Related]
10. The Ubiquitin Proteasome System in Hematological Malignancies: New Insight into Its Functional Role and Therapeutic Options.
Di Costanzo A; Del Gaudio N; Conte L; Altucci L
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32674429
[TBL] [Abstract][Full Text] [Related]
11. The science of puromycin: From studies of ribosome function to applications in biotechnology.
Aviner R
Comput Struct Biotechnol J; 2020; 18():1074-1083. PubMed ID: 32435426
[TBL] [Abstract][Full Text] [Related]
12. p53-Dependent Apoptotic Effect of Puromycin via Binding of Ribosomal Protein L5 and L11 to MDM2 and its Combination Effect with RITA or Doxorubicin.
Jung JH; Lee H; Kim JH; Sim DY; Ahn H; Kim B; Chang S; Kim SH
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 31022952
[TBL] [Abstract][Full Text] [Related]
13. Puromycins B-E, Naturally Occurring Amino-Nucleosides Produced by the Himalayan Isolate Streptomyces sp. PU-14G.
Abbas M; Elshahawi SI; Wang X; Ponomareva LV; Sajid I; Shaaban KA; Thorson JS
J Nat Prod; 2018 Nov; 81(11):2560-2566. PubMed ID: 30418763
[TBL] [Abstract][Full Text] [Related]
14. Puromycin based inhibitors of aminopeptidases for the potential treatment of hematologic malignancies.
Singh R; Williams J; Vince R
Eur J Med Chem; 2017 Oct; 139():325-336. PubMed ID: 28803047
[TBL] [Abstract][Full Text] [Related]
15. Highly functionalized tetrahydropyridines are cytotoxic and selective inhibitors of human puromycin sensitive aminopeptidase.
Aeluri R; Ganji RJ; Marapaka AK; Pillalamarri V; Alla M; Addlagatta A
Eur J Med Chem; 2015 Dec; 106():26-33. PubMed ID: 26513642
[TBL] [Abstract][Full Text] [Related]
16. Specific nonpeptide inhibitors of puromycin-sensitive aminopeptidase with a 2,4(1H,3H)-quinazolinedione skeleton.
Kakuta H; Tanatani A; Nagasawa K; Hashimoto Y
Chem Pharm Bull (Tokyo); 2003 Nov; 51(11):1273-82. PubMed ID: 14600372
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, anticancer activity, and molecular modeling of etodolac-thioether derivatives as potent methionine aminopeptidase (type II) inhibitors.
Çoruh I; Çevik Ö; Yelekçi K; Djikic T; Küçükgüzel ŞG
Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700195. PubMed ID: 29575045
[TBL] [Abstract][Full Text] [Related]
18. Positioning of aminopeptidase inhibitors in next generation cancer therapy.
Hitzerd SM; Verbrugge SE; Ossenkoppele G; Jansen G; Peters GJ
Amino Acids; 2014 Apr; 46(4):793-808. PubMed ID: 24385243
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
